RLMD

Relmada Therapeutics, Inc. RLMD

RLMD
Relmada Therapeutics, Inc. ACRV
Acrivon Therapeutics, Inc. Common Stock PMVP
PMV Pharmaceuticals, Inc. IMUX
Immunic, Inc. TCRX
TScan Therapeutics, Inc. VXRT
Vaxart, Inc. LITS
Lite Strategy, Inc. FBIO
Fortress Biotech, Inc. RPTX
Repare Therapeutics Inc. CBUS
Cibus, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RLMD ACRV PMVP IMUX TCRX VXRT LITS FBIO RPTX CBUS
6M 539.20 % 100.00 % 8.26 % -21.77 % -38.19 % -37.89 % -66.45 % 91.80 % 57.04 % 7.59 %
YTD 899.78 % -57.47 % -22.88 % -41.14 % -69.19 % -48.52 % -66.45 % 65.57 % 68.94 % -47.30 %
1Y 1 144.12 % -66.44 % -22.37 % -44.92 % -67.95 % -37.36 % -66.45 % 92.86 % 52.74 % -58.40 %
3Y 514.33 % -78.96 % -86.58 % -46.87 % -43.34 % -59.34 % -66.45 % -57.45 % -84.93 % -81.65 %
5Y -35.71 % -85.46 % -97.36 % -96.73 % -90.93 % -95.13 % -66.45 % -92.89 % -93.38 % -99.32 %
10Y 73.08 % -85.46 % -96.85 % -99.85 % -90.93 % -98.18 % -66.45 % -90.53 % -92.76 % -99.72 %
From the beginning -62.50 % -85.46 % -96.85 % -99.87 % -90.93 % -99.68 % -66.45 % -97.87 % -92.76 % -99.72 %

Dividend

Vaxart, Inc.